0001209191-17-054555.txt : 20171002 0001209191-17-054555.hdr.sgml : 20171002 20171002154443 ACCESSION NUMBER: 0001209191-17-054555 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171002 FILED AS OF DATE: 20171002 DATE AS OF CHANGE: 20171002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CAUWENBERGH GEERT CENTRAL INDEX KEY: 0001285648 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36304 FILM NUMBER: 171114454 MAIL ADDRESS: STREET 1: 1 STULTS DRIVE CITY: PLAINSBORO STATE: NJ ZIP: 08536 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RXi Pharmaceuticals Corp CENTRAL INDEX KEY: 0001533040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 BUSINESS PHONE: (508) 767-3861 MAIL ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-10-02 0 0001533040 RXi Pharmaceuticals Corp RXII 0001285648 CAUWENBERGH GEERT C/O RXI PHARMACEUTICALS CORPORATION 257 SIMARANO DRIVE, SUITE 101 MARLBOROUGH MA 01752 1 1 0 0 President & CEO Common stock, $0.0001 par value 2017-10-02 4 P 0 2700 0.44 A 135283 D Common stock, $0.0001 par value 2017-10-02 4 P 0 200 0.46 A 135483 D Common stock, $0.0001 par value 2017-10-02 4 P 0 7100 0.45 A 142583 D Common stock, $0.0001 par value 4500 I By spouse Common stock, $0.0001 par value 450 I By son Represents shares held by the Reporting Person's son. The Reporting Person disclaims beneficial ownership of such shares and this report shall not constitute an admission of beneficial ownership. Caitlin Kontulis, attorney-in-fact 2017-10-02